Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

Thomas Jiborn, Magnus Abrahamson, Virgil Gadaleanu, Åke Lundwall, Anders Bjartell

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)189-196
JournalBJU International
Volume98
Issue number1
DOIs
Publication statusPublished - 2006

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Division of Clinical Chemistry and Pharmacology (013250300), Pediatrics/Urology/Gynecology/Endocrinology (013240400), Clinical Chemistry, Malmö (013016000), Division of Urological Cancers (013243420)

Subject classification (UKÄ)

  • Urology and Nephrology

Free keywords

  • Research Support
  • Aged
  • Prostatic Neoplasms: pathology
  • Non-U.S. Gov't
  • Cell Transformation
  • Prostatic Neoplasms: metabolism
  • Chromogranins: metabolism
  • Cystatins: metabolism
  • Disease Progression
  • Humans
  • Ki-67 Antigen: metabolism
  • Male
  • Middle Aged
  • Neuroendocrine Tumors: metabolism
  • Neuroendocrine Tumors: pathology
  • Neoplastic

Cite this